There is a large amount of evidence regarding the fact that elevated levels of NT-proBNP had similar predictive value for adverse CV outcomes, irrespective of AF status, in HFrEF as well as in non-HF patients with different forms of AF [28,29]. This evidence concerns the gene NPPB and atrial fibrillation.